Get the Stockscreener App
144.57
0.97%
-1.41
After Hours:
144.57
Davita Inc stock is traded at $144.57, with a volume of 620.99K.
It is down -0.97% in the last 24 hours and up +1.49% over the past month.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
See More
Previous Close:
$145.98
Open:
$145.59
24h Volume:
620.99K
Relative Volume:
0.80
Market Cap:
$10.92B
Revenue:
$12.82B
Net Income/Loss:
$936.34M
P/E Ratio:
13.46
EPS:
10.74
Net Cash Flow:
$1.47B
1W Performance:
-4.46%
1M Performance:
+1.49%
6M Performance:
-18.09%
1Y Performance:
+5.94%
1-Day Range:
$143.59
$146.66
1-Week Range:
$142.88
$151.59
52-Week Range:
$131.76
$179.60
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
144.57 | 10.98B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
355.06 | 81.93B | 72.70B | 5.97B | 7.29B | 23.79 |
|
FMS
Fresenius Medical Care Ag Adr
|
25.80 | 15.16B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
THC
Tenet Healthcare Corp
|
160.89 | 14.54B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
109.96 | 10.80B | 5.51B | 494.70M | 386.40M | 4.84 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against DaVita Inc. and Encourages Investors with Losses to Contact the Firm - ACCESS Newswire
DaVita Insiders Sell US$34m Of Stock, Possibly Signalling Caution - 富途牛牛
DaVita HealthCare (DVA) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Is DaVita Inc. stock overvalued or undervaluedBest Dividend Report From AI Tools - jammulinksnews.com
How strong is DaVita Inc. company’s balance sheetEarnings Report Alerts To Watch Now - jammulinksnews.com
What markets is DaVita Inc. expanding into Is VIST stock a good long term investment optionMassive stock growth - jammulinksnews.com
Is DaVita Inc. a growth stock or a value stockCapitalize on market shifts before others do - jammulinksnews.com
What is DaVita Inc. company’s growth strategyBuild wealth faster with disciplined trading - jammulinksnews.com
Is it the right time to buy DaVita Inc. stockRecord-setting profit potential - jammulinksnews.com
What is the risk reward ratio of investing in DaVita Inc. stockUnlock powerful trading signals and alerts - jammulinksnews.com
Should I hold or sell DaVita Inc. stock in 2025Jaw-dropping returns - jammulinksnews.com
How does DaVita Inc. compare to its industry peersExpert guidance for superior capital growth - jammulinksnews.com
What are analysts’ price targets for DaVita Inc. in the next 12 monthsExceptional trading results - jammulinksnews.com
What institutional investors are buying DaVita Inc. stockNavigate the market with precision tools - jammulinksnews.com
What makes DaVita Inc. stock price move sharplyCapital Doubling Tips - metal.it
DaVita Inc. Stock Analysis and ForecastRapid growth trajectories - PrintWeekIndia
Inside Out: Analyzing Insider Selling at Davita and Its Implications for Investors - AInvest
Is DaVita Inc. a good long term investmentConsistently high yield - Autocar Professional
DaVita Inc chief compliance officer Hearty sells $352k in stock - Investing.com Nigeria
Insider Sell Alert: James Hearty Sells Shares of DaVita Inc (DVA) - GuruFocus
What analysts say about DaVita Inc. stockExplosive earning power - jammulinksnews.com
What drives DaVita Inc. stock priceSkyrocketing investment returns - Autocar Professional
How Investors May Respond To DaVita (DVA) Credit Agreement Amendment and $250M Loan Raise - simplywall.st
DaVita HealthCare (DVA) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
For Sale: DaVita Dialysis building in Willow Grove | $3,710,000 - Glenside Local
DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential Amidst Strong ROE and Revenue Growth - DirectorsTalk Interviews
Lobbying Update: $90,000 of DAVITA INC. lobbying was just disclosed - Nasdaq
DaVita’s Quarterly Earnings Preview: What You Need to Know - MSN
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.57%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):